Stockhead on MSN9h
Health Check: Awaiting key announcements, these biotechs could use some Irish luck
On St Patrick's Day, investors hope for the luck of the Irish ahead of Opthea's key trial update and Imricor's ambitious fund ...
Center for Biosimilars23h
Retina Specialists’ Evolving View on Biosimilars in AMD Treatment
The introduction of biosimilars in the treatment of age-related macular degeneration (AMD) is raising concerns among physicians about cost-driven mandates and the autonomy to choose the best therapies ...